Search

In this study, Lactobacillus paracasei FP02, a strain isolated from pickled Chinese cabbage, was tested for its capability to reduce uric acid in vitro, and its physiological and biochemical characteristics were characterized. Furthermore, the effect of this strain on the serum uric acid level of a hyperuricemic (HUA) rat model was explored. The in vitro results showed that L. paracasei FP02 degraded uric acid and its precursor substances, inosine and guanosine, by 29.10%, 67.09%, and 70.48%, respectively, and inhibited xanthine oxidase (XOD) activity by 64.20%. Simultaneously, this strain could ferment various sugars (alcohols) and exhibited good tolerance to gastric acid and bile salts. The 14-day continuous intragastric administration of freeze-dried L. paracasei FP02 powder reduced the serum uric acid concentration by 49.96% compared to the hyperuricemia model group (P < 0.001), which was established by intragastric administration of potassium oxonate combined with high dietary uric acid. After the treatment, the serum uric acid concentration approached the levels observed in the blank control group. Additionally, in the FP02 treatment group, uric acid excretion in the urine increased, and serum XOD activity was significantly inhibited (P < 0.001). Renal sections showed that renal injury was partially restored in the FP02 treatment group. This study will lay the foundation for the development of L. paracasei FP02 as a potential drug or functional food for preventing HUA.

In this study, the genomes of 19 Latilactobacillus curvatus and 40 L. sakei strains were comparatively analyzed. Average nucleic acid identity (ANI) and genome-wide colinearity indicated that the genomes of L. curvatus and L. sakei had weak nucleotide sequence homology, allowing them to be used as indicators to distinguish the two species. Pangenomes for these species were constructed, whose core gene functions were annotated. The results showed that the core genomes of L. curvatus and L. sakei were mainly involved in their basic metabolism. Analysis of individual genomes of the strains revealed that 1) both L. curvatus and L. sakei contained a wide range of genes encoding glycoside hydrolases, which are abundant genetic resources for catabolizing and metabolizing dietary fiber such as polysaccharides, lactose utilization, and lignocellulose; 2) antibiotic resistance genes were annotated in the genomes of three strains, which originate from horizontal gene transfer; 3) the unique arginine deiminase pathway of L. sakei, the serine dehydratase and guanine deaminase pathways of L. curvatus, and the glutamate decarboxylase pathway of several strains were identified, revealing that the acid tolerance mechanisms of these two species are different; and 4) genes encoding cold stress proteins were discovered, which endow the two species with good cold processing properties. Moreover, the genomes of some L. sakei strains contained gene clusters related to the biosynthesis of lactocin S and condensin. In conclusion, this study established taxonomic criteria for the two species and information on individual differences between their strains, which will provide a basis for the study of the physiological, biochemical, molecular genetic mechanisms of L. curvatus and L. sakei and their industrial applications.

Non-starch polysaccharides (NSPs) have been reported to exert therapeutic potential on managing type 2 diabetes mellitus (T2DM). Various mechanisms have been proposed; however, several studies have not considered the correlations between the anti-T2DM activity of NSPs and their molecular structure. Moreover, the current understanding of the role of NSPs in T2DM treatment is mainly based on in vitro and in vivo data, and more human clinical trials are required to verify the actual efficacy in treating T2DM. The related anti-T2DM mechanisms of NSPs, including regulating insulin action, promoting glucose metabolism and regulating postprandial blood glucose level, anti-inflammatory and regulating gut microbiota (GM), are reviewed. The structure-function relationships are summarized, and the relationships between NSPs structure and anti-T2DM activity from clinical trials are highlighted. The development of anti-T2DM medication or dietary supplements of NSPs could be promoted with an in-depth understanding of the multiple regulatory effects in the treatment/intervention of T2DM. [ABSTRACT FROM AUTHOR]